Merck KGaA Price Chart
Merck KGaA MRK1N.MX Financial and Trading Overview
| Merck KGaA stock price | 2878.21 MXN |
| Previous Close | 3358.91 MXN |
| Open | 0 MXN |
| Bid | 0 MXN x N/A |
| Ask | 0 MXN x N/A |
| Day's Range | 3358.91 - 3358.91 MXN |
| 52 Week Range | 3358.91 - 3358.91 MXN |
| Volume | 0 MXN |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.623371 |
| PE Ratio (TTM) | 21.433239 |
| EPS (TTM) | 156.72 MXN |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MRK1N.MX Valuation Measures
| Enterprise Value | 1.47T MXN |
| Trailing P/E | 21.433239 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 55.87381 |
| Enterprise Value/Revenue | 65.841 |
| Enterprise Value/EBITDA | 228.125 |
Trading Information
Merck KGaA Stock Price History
| Beta (5Y Monthly) | 0.623371 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3358.91 MXN |
| 52 Week Low | 3358.91 MXN |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
MRK1N.MX Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | 129.24M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 58.63% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.2 |
| Trailing Annual Dividend Yield | 0.065% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 14.52% |
| Operating Margin (ttm) | 21.82% |
| Gross Margin | 62.01% |
| EBITDA Margin | 28.86% |
Management Effectiveness
| Return on Assets (ttm) | 6.42% |
| Return on Equity (ttm) | 13.23% |
Income Statement
| Revenue (ttm) | 22.33B MXN |
| Revenue Per Share (ttm) | 51.37 MXN |
| Quarterly Revenue Growth (yoy) | 1.79% |
| Gross Profit (ttm) | 13.74B MXN |
| EBITDA | 6.44B MXN |
| Net Income Avi to Common (ttm) | 3.24B MXN |
| Diluted EPS (ttm) | 156.715 |
| Quarterly Earnings Growth (yoy) | -9.50% |
Balance Sheet
| Total Cash (mrq) | 1.72B MXN |
| Total Cash Per Share (mrq) | 3.96 MXN |
| Total Debt (mrq) | 10.64B MXN |
| Total Debt/Equity (mrq) | 40.58 MXN |
| Current Ratio (mrq) | 1.355 |
| Book Value Per Share (mrq) | 60.116 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.27B MXN |
| Levered Free Cash Flow (ttm) | 1.42B MXN |
Profile of Merck KGaA
| Country | Mexico |
| State | N/A |
| City | Darmstadt |
| Address | Frankfurter Strasse 250 |
| ZIP | 64293 |
| Phone | 49 6151 72 0 |
| Website | https://www.merckgroup.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 64011 |
Merck KGaA operates as a science and technology company in Germany. The company's Life Science segment offers a range of products, including reagents, consumable, devices, instruments, software, and services for scientific discovery, as well as provides lab water instruments, consumables and services, microbiology and biomonitoring, products, test assays, analytical reagents, and flow cytometry kits and instruments for pharma and biotech, industrial and testing, academics and government, and diagnostic sectors. Its Healthcare segment designs and develops medicines and intelligent devices for treatment of various therapeutics, such as oncology, neurology and immunology, endocrinology, and general medicines. The company's Electronic segment provides semiconductor solutions, such as semiconductor materials, delivery systems and services, and intermolecular services for semiconductor and polymer removal chemistries applications; and display solutions comprising liquid crystals, OLED and quantum materials, reactive mesogens, photoresist materials, smart antenna, and dynamic liquid crystal glazing products, as well as offers liviFlex, a flexible platform, which offers a range of display materials. This segment also provides surface solution, such as cosmetics, effect pigments, and functional solutions; architecture solutions, including switchable windows; and automotive solutions. In addition, it has strategic alliances with Pfizer Inc. and GlaxoSmihKline plc to develop and commercialize active ingredients in immune-oncology; in-licensing agreement with Debiopharm International SA for developing drug candidates for the treatment of head and neck cancer; and out-licensing agreement with MoonLake Immunotherapeutics AG for developing a drug candidate for the treatment of inflammatory diseases. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA is a subsidiary of E. Merck Kommanditgesellschaft.
Q&A For Merck KGaA Stock
What is a current MRK1N.MX stock price?
Merck KGaA MRK1N.MX stock price today per share is 2878.21 MXN.
How to purchase Merck KGaA stock?
You can buy MRK1N.MX shares on the Mexico exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Merck KGaA?
The stock symbol or ticker of Merck KGaA is MRK1N.MX.
How many shares does Merck KGaA have in circulation?
The max supply of Merck KGaA shares is 0.
What is Merck KGaA Price to Earnings Ratio (PE Ratio)?
Merck KGaA PE Ratio is 18.36588700 now.
What was Merck KGaA earnings per share over the trailing 12 months (TTM)?
Merck KGaA EPS is 156.72 MXN over the trailing 12 months.